Opioid treatment at release from jail using extended‐release naltrexone: a pilot proof‐of‐concept randomized effectiveness trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1360-0443|110|6|1008-1014

ISSN： 0965-2140

Source： ADDICTION, Vol.110, Iss.6, 2015-06, pp. : 1008-1014

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended‐release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo‐controlled trial

By  

ADDICTION, Vol. 113, Iss. 2, 2018-02 ,pp. : 268-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ling et al.’s ‘Sustained‐release methylphenidate in a randomized trial of treatment of methamphetamine use disorder’

By  

ADDICTION, Vol. 110, Iss. 5, 2015-05 ,pp. : 875-876

John Wiley & Sons Inc

Access to resources Recommend Favorite

A cost‐effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence

By  

ADDICTION, Vol. 110, Iss. 12, 2015-12 ,pp. : 1975-1984

John Wiley & Sons Inc

Access to resources Recommend Favorite

RIOTT secondary outcomes

By  

ADDICTION, Vol. 110, Iss. 3, 2015-03 ,pp. : 479-490

John Wiley & Sons Inc

Access to resources Recommend Favorite

Commentary on Metrebian et al (2015): What is addiction treatment research about? Some comments on the secondary outcomes of the Randomized Injectable Opioid Treatment Trial

By  

ADDICTION, Vol. 110, Iss. 3, 2015-03 ,pp. : 491-493

John Wiley & Sons Inc

Access to resources Recommend Favorite